ISRCTN57795429
Completed
N/A
Randomized placebo-controlled trial in children and adults with ADHD of the effect of Synbiotic2000Forte on symptoms and function.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Attention-deficit hyperactivity disorder
- Sponsor
- Karolinska Institutet
- Enrollment
- 182
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32497779/ results (added 26/10/2020) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36904292/ (added 14/06/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. ADHD diagnosis
- •2\. Swedish speaker
- •3\. Aged 5\-55 years old
Exclusion Criteria
- •1\. Autism diagnosis
- •2\. Gastrointestinal diagnosis other than IBS
- •3\. Diabetes
- •4\. Antibiotic drug treatment last six weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Evaluation of immune modulation by beta-glucan, a soluble dietary fiber derived from reishi mushroom in healthy adult volunteers, a systemic clinical trialISRCTN48306294Super Beta Glucan Inc., Biomedical Research Division173
Completed
N/A
Clinical trial for proving the efficacy of heat-inactivated Bifidobacterium bifidum SYN-HI-001 in the treatment of irritable bowel syndromeIrritable bowel syndrome (IBS)Digestive SystemISRCTN14066467Synformulas GmbH507
Completed
N/A
Enterosgel® in the treatment of Irritable Bowel Syndrome with DiarrhoeaISRCTN17149988Enteromed Ltd439
Completed
N/A
The Canadian Nocturnal Oxygen (CANOX) trialChronic obstructive pulmonary disease (COPD)RespiratoryOther chronic obstructive pulmonary diseaseISRCTN50085100aval Hospital (Hôpital Laval) (Canada)243
Completed
Phase 1
Testing the safety and effects of a new drug (G3215) in adult subjectsDiabetes Mellitus ObesityNutritional, Metabolic, EndocrineISRCTN67889041Imperial College London24